R

Rafael Holdings
D

RFL

1.99000
USD
-0.05
(-2.45%)
Market Closed
Volume
141
EPS
0
Div Yield
-
P/E
-1
Market Cap
49,778,375
Related Instruments
    C
    CHH
    -1.640
    (-1.08%)
    150.410 USD
    H
    H
    -5.713
    (-3.92%)
    140.047 USD
    HLT
    HLT
    -8.29
    (-3.10%)
    259.55 USD
    H
    HTZ
    -0.30500
    (-6.79%)
    4.19000 USD
    I
    IHG
    -4.385
    (-3.41%)
    124.310 USD
    MAR
    MAR
    -9.88
    (-3.44%)
    277.48 USD
    W
    WH
    -3.040
    (-2.72%)
    108.880 USD
    More
News

Title: Rafael Holdings

Sector: Real Estate
Industry: Real Estate Services
Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.